Skip to content
Translational Neuropharmacology Lab (Zanos Lab)

Translational Neuropharmacology Lab (Zanos Lab)

Our laboratory, based in Cyprus, employs molecular and systems neuroscience, behavioral pharmacology, as well as advanced computational methods to unravel the mysteries of brain diseases and identify targets for the development of novel and effective pharmacotherapies.

Menu
  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Category: News

News

Dr. Polymnia Louka’s inspiring talk at the European University Cyprus annual conference

No Comments
| News

The Zanos Lab is delighted to share that Dr. Polymnia Louka, our Marie Skłodowska-Curie Fellow, delivered an engaging talk at the European University Cyprus (EUC) Annual Conference. Invited to address students and faculty, Dr. Louka discussed her journey to securing the prestigious and competitive Marie Curie Fellowship, as well as her innovative research exploring the […]

Read More »

Zanos Lab part of the newly-awarded European COST action “PSY-NET” (Psychedelic renaissance)

No Comments
| News

We are pleased to announce that the Zanos Lab at the University of Cyprus is an integral part of the newly awarded COST Action “PSY-NET: Psychedelic renaissance: turn on, tune in and drop in” (OC-2024-1-27517). This collaborative network brings together 83 leading researchers from 21 European countries to advance psychedelic research across multiple disciplines. The […]

Read More »

Zanos Lab research on biomarkers of nicotine addiction relapse presented at the Hellenic Psychological Society conference

No Comments
| News

The Zanos Lab is pleased to announce that Dr. Apostolakis has presented research at the Hellenic Psychological Society (ΕΛΨΕ) conference in Ioannina, Greece. The presentation, titled “Stress biomarkers and emotion regulation difficulties as predictive factors of vulnerability to nicotine addiction relapse,” addressed a critical challenge in smoking cessation efforts. Nicotine addiction is characterized by high […]

Read More »

Dr. Zanos presented groundbreaking ketamine research at University of Bern’s Neuroscience lecture series

No Comments
| News

We are pleased to announce that Dr. Panos Zanos, Director of the Zanos Lab at the University of Cyprus, recently delivered a lecture as part of the prestigious Neuroscience Lecture Series (NLS) at the University of Bern, Switzerland, for the 2024/25 academic year. Dr. Zanos presented the lab’s cutting-edge research on ketamine’s antidepressant properties, challenging […]

Read More »

Zanos Lab research decodes molecular pathways in Opioid Use Disorder and Depression at Hellenic Psychological Society conference

No Comments
| News

Dr. Zanos has presented new research of our lab at the Hellenic Psychological Society (ΕΛΨΕ) conference in Ioannina, Greece. The presentation, titled “Decoding common molecular pathways affected in opioid use disorder and depression,” explored the complex relationship between these frequently co-occurring conditions. This research was led by our lab members, Drs. Anna Onisiforou and Andrea […]

Read More »

Our postdoctoral fellow, Dr. Andria Michael, presents at YUFE4Postdocs workshop in University of Antwerp

No Comments
| News

We are pleased to announce that our postdoctoral researcher, Dr. Andria Michael, recently participated in the YUFE4Postdocs training workshop hosted at the University of Antwerp. The workshop focused on stakeholder interaction and open science practices, bringing together talented postdoctoral researchers from across the YUFE alliance. During this spring workshop, Dr. Michael had the opportunity to […]

Read More »

Zanos Lab postdoctoral researcher Dr. Polymnia Louka contributes expert article on depression and bone health

No Comments
| News

We are pleased to announce that Dr. Polymnia Louka of the Zanos Laboratory recently authored an informative article in a prominent Cypriot newspaper addressing the important relationship between depression and bone health. In her article, Dr. Louka explains that depression is one of the most common psychiatric disorders in the modern world, affecting approximately 5% […]

Read More »

Zanos Lab Awarded $100,000 IDSA Foundation Grant for Alzheimer’s Research

No Comments
| News

We are pleased to announce that Dr. Anna Onisiforou and Dr. Zanos  have been awarded a $100,000 grant from the Infectious Diseases Society of America (IDSA) Foundation. The grant will support an innovative project entitled “Sex-Specific Mechanisms of HSV-1 and EBV in Alzheimer’s Disease Risk.” This competitive funding was awarded through the 2025 Microbial Pathogenesis […]

Read More »

Cyprus Neuroscience Society now officially established: A historic milestone for Cyprus’ neuroscience community led by Dr. Zanos

No Comments
| News

The Translational Neuropharmacology Lab is proud to announce that the Cyprus Neuroscience Society (C.N.S.), founded and presided over by our Principal Investigator Dr. Panos Zanos, has reached another significant milestone with the launch of its official website: cnscyprus.com. This achievement builds upon Dr. Zanos’s vision to establish the first-ever neuroscience society in Cyprus (Registration Number: […]

Read More »

Dr. Zanos discusses innovative ketamine research at the American College of Greece (Deeree) faculty seminar

No Comments
| News

On Tuesday, April 8th, Dr. Zanos, Head of the Translational Neuropharmacology Lab, presented his groundbreaking research on ketamine’s antidepressant properties to faculty and students at Deree. The seminar, held in the Faculty Lounge, provided an intimate setting for in-depth discussion of novel therapeutic approaches to depression treatment. Dr. Zanos’s presentation explored the molecular pathways through […]

Read More »

Posts pagination

Previous 1 2 3 4 … 11 Next

Recent Posts

  • New pre-print: VirTarget framework reveals how Multiple Sclerosis immunotherapies engage with Epstein-Barr Virus-driven disease mechanisms November 6, 2025
  • New preprint: VirTrack framework reveals stage-specific EBV pathogenesis in Multiple Sclerosis October 26, 2025
  • Translational Neuropharmacology Lab presents on novel therapies for brain disorders October 25, 2025
  • Dr. Zanos was invited and presented on antidepressant mechanisms of action of ketamine and other rapid-acting antidepressants at the 6th German-Cypriot Psychotherapy Conference October 7, 2025
  • Featured in Nature Mental Health: Advancing ketamine research and brain pathology treatments October 3, 2025

Navigation

  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Translational Neuropharmacology Lab (Zanos Lab) 2025 . Powered by WordPress